MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) Interest Coverage: 1.41 (As of Mar. 2026) — 71% Below Median


IST:MEDTR MEDITERA TIBBI MALZEME SANAYI VE TICARET AS IST:MEDTR
82 GF Score
Price ₺28.24
GF Value ₺43.55
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is MEDITERA TIBBI MALZEMENAYI VE TICARET AS Interest Coverage?

MEDITERA TIBBI MALZEMENAYI VE TICARET AS IST:MEDTR -1.33% 82 Interest Coverage is 1.41 as of Mar. 2026, which is 71% below its 10-year median of 4.93. GuruFocus rates IST:MEDTR with a GF Score™ of 82/100 and a GF Value™ of ₺43.55 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 466 Medical Devices & Instruments companies, MEDITERA TIBBI MALZEMENAYI VE TICARET AS ranks worse than 87.34% on this metric.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Operating Income for the three months ended in Mar. 2026 was ₺16 Mil. MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Interest Expense for the three months ended in Mar. 2026 was ₺-11 Mil. MEDITERA TIBBI MALZEMENAYI VE TICARET AS's interest coverage for the quarter that ended in Mar. 2026 was 1.41. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Interest Coverage or its related term are showing as below:

IST:MEDTR' s Interest Coverage Range Over the Past 10 Years
Min: 2.43   Med: 4.93   Max: 13.11
Current: 2.56

IST:MEDTR's Interest Coverage is ranked worse than
87.34% of 466 companies
in the Medical Devices & Instruments industry
Industry Median: 15.875 vs IST:MEDTR: 2.56

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS  (IST:MEDTR) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Interest Coverage Related Terms

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Interest Coverage Historical Data

* Premium members only.

The historical data trend for MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Interest Coverage Chart

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Interest Coverage
Get a 7-Day Free Trial 6.74 9.93 5.05 3.33 2.43

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.47 12.22 2.01 1.19 1.41

IST:MEDTR vs ABT, SYK, MDT: Interest Coverage Comparison

For the Medical Devices subindustry, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Interest Coverage vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Interest Coverage distribution charts can be found below:

* The bar in red indicates where MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Interest Coverage falls into.


IST:MEDTR
82GF Score
MEDITERA TIBBI MALZEME SANAYI VE TICARET AS IST:MEDTR
Interest Coverage is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Interest Coverage for the fiscal year that ended in Dec. 2025 is calculated as

Here, for the fiscal year that ended in Dec. 2025, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Interest Expense was ₺-47 Mil. Its Operating Income was ₺115 Mil. And its Long-Term Debt & Capital Lease Obligation was ₺14 Mil.

Interest Coverage=-1* Operating Income (A: Dec. 2025 )/Interest Expense (A: Dec. 2025 )
=-1*114.864/-47.362
=2.43

MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Here, for the three months ended in Mar. 2026, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Interest Expense was ₺-11 Mil. Its Operating Income was ₺16 Mil. And its Long-Term Debt & Capital Lease Obligation was ₺10 Mil.

Interest Coverage=-1* Operating Income (Q: Mar. 2026 )/Interest Expense (Q: Mar. 2026 )
=-1*15.831/-11.249
=1.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

Frequently Asked Questions Learn more about Interest Coverage →
What does a Interest Coverage of 1.41 mean?
MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) has a Interest Coverage of 1.41 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on MEDITERA TIBBI MALZEMENAYI VE TICARET AS and its competitors. This is 71% below median its historical median of 4.93. Over the past decade, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Interest Coverage has ranged from 2.43 to 13.11. According to the industry distribution chart, MEDITERA TIBBI MALZEMENAYI VE TICARET AS ranks #407 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 87.3%.
Is MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Interest Coverage too high?
MEDITERA TIBBI MALZEMENAYI VE TICARET AS's current Interest Coverage of 1.41 is 71% below median its 10-year median of 4.93. Over the past 10 years, this metric has ranged from a low of 2.43 to a high of 13.11. The Medical Devices & Instruments industry median Interest Coverage is 15.88. MEDITERA TIBBI MALZEMENAYI VE TICARET AS's value of 1.41 is 91.1% below this industry median. Based on the distribution chart, MEDITERA TIBBI MALZEMENAYI VE TICARET AS ranks #407 out of 466 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, MEDITERA TIBBI MALZEMENAYI VE TICARET AS has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does MEDITERA TIBBI MALZEMENAYI VE TICARET AS's Interest Coverage compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, MEDITERA TIBBI MALZEMENAYI VE TICARET AS ranks #407 out of 466 companies for Interest Coverage. This places MEDITERA TIBBI MALZEMENAYI VE TICARET AS in the lower half of its industry. The industry median Interest Coverage is 15.88. MEDITERA TIBBI MALZEMENAYI VE TICARET AS's value of 1.41 is 91.1% below this benchmark. Historically, MEDITERA TIBBI MALZEMENAYI VE TICARET AS's own Interest Coverage has ranged from 2.43 to 13.11 over the past decade. While the company's 10-year median is 4.93 vs. the industry median of 15.88, MEDITERA TIBBI MALZEMENAYI VE TICARET AS has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.88, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MEDITERA TIBBI MALZEMENAYI VE TICARET AS's current Interest Coverage of 1.41 is 91.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on MEDITERA TIBBI MALZEMENAYI VE TICARET AS and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MEDITERA TIBBI MALZEMENAYI VE TICARET AS's current Interest Coverage is 1.41, which is 71% below median its own 10-year median of 4.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MEDITERA TIBBI MALZEMENAYI VE TICARET AS stock overvalued right now?
Based on GuruFocus' analysis, MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) is currently considered Significantly Undervalued. The stock's GF Value™ is ₺43.55, compared to a current price of ₺28.24 — trading 35.2% below its estimated fair value. The current Interest Coverage is 1.41, which is 71% below median its 10-year median of 4.93 and 91.1% below the Medical Devices & Instruments industry median of 15.88. MEDITERA TIBBI MALZEMENAYI VE TICARET AS's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR), the current Interest Coverage is 1.41 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MEDITERA TIBBI MALZEMENAYI VE TICARET AS (IST:MEDTR) Overvalued in 2026?

Based on GuruFocus' analysis, MEDITERA TIBBI MALZEMENAYI VE TICARET AS stock appears to be undervalued. The current stock price of ₺28.24 is trading 35.2% below its estimated GF Value™ of ₺43.55. GuruFocus considers MEDITERA TIBBI MALZEMENAYI VE TICARET AS to be Significantly Undervalued.

Key valuation signals for IST:MEDTR:

  • Interest Coverage: 1.41 (71% below median its 10-year median of 4.93)
  • GF Value™: ₺43.55 vs. price of ₺28.24 (35.2% below fair value)
  • GF Score™: 82/100 with 5 warning signs
  • Industry Position: 91.1% below the Medical Devices & Instruments median (#407 of 466)

No single metric tells the full story. See the IST:MEDTR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MEDITERA TIBBI MALZEMENAYI VE TICARET AS Business Description

Address Sokak No: 29 Tire Organize Sanayi, Ibni Melek OSB Mahallesi, TOSBI Yol 4, Bolgesi Tire, Izmir, TUR, 35900
MEDITERA TIBBI MALZEME SANAYI VE TICARET AS is engaged in the manufacture of anesthesia and intensive care circuits, the installation, operation, and design of oncology drug preparation and delivery systems, production, sales, and technical service of infusion pumps and sets, and the manufacture of biocidal products.
82GF Score

Get the complete analysis for IST:MEDTR

Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺28.24
Price
₺43.55
GF Value